Jim St. John is the new Vice President International Sales at Pioneer Surgical Technology, Inc..
St. John Heads Pioneer’s International Sales

St. John has lived in Europe for over 12 years, speaks five languages and has 25 years of experience in the spine industry.
A company spokesperson told OTW on March 9 that leaders at Pioneer realize that the markets outside the U.S. have always been a hotbed for new innovative spine technologies. Many promising ideas and products originated with thought leader spine surgeons based in major OUS countries. “Pioneer wants to further engage with these individuals to assist with their data collection, product ideas and to assist them with introducing cost reducing therapies to this market. Accordingly, Pioneer is excited to appoint a very experienced international spine manager to establish their strategy and lead this initiative.”
St. John last worked for Benvenue Medical where he had the role of Vice President Worldwide Sales & Marketing. Before that he worked for Zimmer Spine and Abbott Spine, with his last position located in Europe where he was the GM of Zimmer Spine SA (Bordeaux, France) and VP of Zimmer Spine EMEA. While with Zimmer Spine, he had sales, marketing and general management responsibilities and was instrumental in developing their international strategy and distribution channels. Twice during his time with Zimmer Spine he led the integration of multiple distribution channels as a result of mergers.
Tom McLeer, Pioneer’s GM of Spine and Chief Marketing Officer said, “Jim will be responsible for establishing our strategy and managing our entire international sales operation. He will provide additional focus in our established territories of Europe and China as well as working to expand into new markets in the world. We are excited to add such strong international talent to our team.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.